GreenVision Acquisition, a blank check company led by Shanghai dealmakers targeting healthcare firms outside of China, raised $50 million by offering 5 million units at $10 to command a market value of $63 million. Each unit consists of one share of common stock, one warrant, and one right to receive one-tenth of a share of common stock.
GreenVision Acquisition plans to list on the Nasdaq under the symbol GRNVU. I-Bankers Securities acted as a lead manager on the deal.
The article Healthcare SPAC GreenVision Acquisition prices $50 million IPO at $10 originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.